{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "9519714", "DateCompleted": {"Year": "1998", "Month": "04", "Day": "03"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "17"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0012-1797", "JournalIssue": {"Volume": "47", "Issue": "2", "PubDate": {"Year": "1998", "Month": "Feb"}}, "Title": "Diabetes", "ISOAbbreviation": "Diabetes"}, "ArticleTitle": "4-Hydroxyisoleucine: a novel amino acid potentiator of insulin secretion.", "Pagination": {"StartPage": "206", "EndPage": "210", "MedlinePgn": "206-10"}, "Abstract": {"AbstractText": ["We report the characterization of a new insulinotropic compound, 4-hydroxyisoleucine. This amino acid has been extracted and purified from fenugreek seeds, which are known in traditional medicine for their antidiabetic properties. 4-Hydroxyisoleucine increases glucose-induced insulin release, in the concentration range of 100 micromol/l to 1 mmol/l, through a direct effect on isolated islets of Langerhans from both rats and humans. The stimulating effect of 4-hydroxyisoleucine was strictly glucose dependent; indeed, ineffective at low (3 mmol/l) or basal (5 mmol/l) glucose concentrations, the amino acid potentiated the insulin secretion induced by supranormal (6.6-16.7 mmol/l) concentrations of glucose. In addition, in the isolated perfused rat pancreas, we could show 1) that the pattern of insulin secretion induced by 4-hydroxyisoleucine was biphasic, 2) that this effect occurred in the absence of any change in pancreatic alpha- and delta-cell activity, and 3) that the more glucose concentration was increased, the more insulin response was amplified. Moreover, 4-hydroxyisoleucine did not interact with other agonists of insulin secretion (leucine, arginine, tolbutamide, glyceraldehyde). Therefore, we conclude that 4-hydroxyisoleucine insulinotropic activity might, at least in part, account for fenugreek seeds' antidiabetic properties. This secretagogue may be considered as a novel drug with potential interest for the treatment of NIDDM."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratoire de Recherche sur les Substances Naturelles V\u00e9g\u00e9tales, Universit\u00e9 Montpellier II, France."}], "LastName": "Sauvaire", "ForeName": "Y", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Petit", "ForeName": "P", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Broca", "ForeName": "C", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Manteghetti", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Baissac", "ForeName": "Y", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Fernandez-Alvarez", "ForeName": "J", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Gross", "ForeName": "R", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Roye", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Leconte", "ForeName": "A", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Gomis", "ForeName": "R", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Ribes", "ForeName": "G", "Initials": "G"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Diabetes", "NlmUniqueID": "0372763", "ISSNLinking": "0012-1797"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "4-hydroxyisoleucine"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Insulin"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "04Y7590D77", "NameOfSubstance": "Isoleucine"}, {"RegistryNumber": "68990-15-8", "NameOfSubstance": "fenugreek seed meal"}, {"RegistryNumber": "IY9XDZ35W2", "NameOfSubstance": "Glucose"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Glucose"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": ["metabolism"], "DescriptorName": "Insulin"}, {"QualifierName": [], "DescriptorName": "Insulin Secretion"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Islets of Langerhans"}, {"QualifierName": ["administration & dosage", "analogs & derivatives", "isolation & purification", "pharmacology"], "DescriptorName": "Isoleucine"}, {"QualifierName": [], "DescriptorName": "Kinetics"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": [], "DescriptorName": "Trigonella"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1998", "Month": "3", "Day": "31"}, {"Year": "1998", "Month": "3", "Day": "31", "Hour": "0", "Minute": "1"}, {"Year": "1998", "Month": "3", "Day": "31", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9519714", "10.2337/diab.47.2.206"]}}]}